Historically, clinical trials have been concentrated at academic medical centers, large hospitals, and cancer centers. But under this approach, trials aren’t as inclusive or accessible as they...
Read Blog
Patient-facing technology can make trials more accessible and help trials fit into participants’ lives. But if we’re not careful, technology built to empower patients may end up overwhelming them...
Read Blog
The lack of diversity in clinical trials is one of the most pressing concerns confronting the clinical research industry. The recent FDA guidance for diversity in clinical trials calls on all...
Read Blog
The number of clinical trials has increased rapidly since 2020. 2021 saw a 14% increase in trial starts over 2020 and a 19% increase over 2019. And while 2020 was far from a typical year, the...
Read Blog
Watch Video
The number of new clinical trials is expected to increase 5.8% each year from 2022 to 2030. But research sites already struggle to keep up with trial workloads. With 1,015 new trials starting in...
Read Blog
Clinical trials can’t avoid fluctuating economic conditions. Changes in the market can especially impact emerging and early-stage biotech companies with limited cash reserves. A clinical trial's...
Read Blog
Read Flipbook
Learn from Catherine Gregor about the newly published FDA draft guidance for increasing participant enrollment from underrepresented racial and ethnic groups in clinical trials.
Watch Video
Multinational clinical trials play an essential role in the European Union. In 2019 alone, Europe hosted 2,900 multinational trials. This was the second-highest number of clinical trials for any...
Read Blog
Decentralized clinical trials (DCTs) –trials that don’t take place exclusively at major sites–have quickly grown in popularity. 89% of sponsors use DCT methods in some of their studies, and so do...
Read Blog
Wondering what’s next in the world of clinical research? Catherine Gregor, Florence’s Chief Clinical Trial Officer and the former Director of Clinical Research Administration at Vanderbilt,...
Read Blog
ATLANTA–(Business Wire)--The first research site to adopt Florence eConsent has successfully registered 250 patients after just 30 days of using the platform. Florence designed eConsent to speed...
Read Blog
Patient experience in clinical trials is a problem. On patient satisfaction surveys, clinical trials received low scores similar to the scores of Internet service providers, utility companies, and...
Read Blog
The first three months of 2022 have seen a 3x uptick over the first three months of 2021 in clinical trial sponsors and CROs contacting Florence about deploying Electronic Investigator Site Files...
Read Blog
Is the Industry Wired for This Revolution? You are almost guaranteed to have heard or seen the word "decentralized" in the last year if you've been to a clinical research conference, looked at...
Read Blog
Clinical trials could help far more patients than they currently do. So how do we expand studies to all of the patients who need them? Community-based clinical trials might be the answer. 70% of...
Read Blog
by Beau Bruneau, Innovations Business Analyst at Florence More than 500 clinical trial professionals signed up for Florence’s February 2022 Innovation Summit, which included roundtable discussions...
Read Blog
Sites and sponsors struggled with clinical trial diversity long before the COVID-19 pandemic began. Roughly 20% of new drugs have different effects depending on a person’s race. This makes it...
Read Blog
by Blake Adams, SVP of Marketing at Florence Missed our fireside chat about how sponsors can work remotely with sites in traditional and decentralized trials? The recording with Nimita Limaye,...
Read Blog
Loading More...
